AprilAire launches the most innovative large bypass Humidifier since inventing the category in 1954- AprilAire, the leader in Healthy Air solutions, introduces the 620 Large Bypass Evaporative Humidifier. The Model 620 expands the HydroCore™ Humidifier Series to deliver best-in-class performance and efficiency*. Setting a new standard in whole-home evaporative humidification, contractors as well as homeowners […]

Important Notice for Long-Term Shareholders of Flywire Corporation (NASDAQ: FLYW); Ibotta, Inc. (NYSE: IBTA); SelectQuote, Inc. (NYSE: SLQT); and Semtech Corporation (NASDAQ: SMTC): Grabar Law Office is Investigating Claims on Your Behalf GlobeNewswire August 22, 2025 PHILADELPHIA, Aug. 22, 2025 (GLOBE NEWSWIRE) — Flywire Corporation (NASDAQ: FLYW): Grabar Law Office is investigating claims on behalf

Proprietary model informs targeted sales and marketing strategies with feedback loop that augmentsprecision and impact of targeting and engagement Citius Oncology, Inc. (“Citius Oncology”) (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. (“Citius Pharma”) (Nasdaq: CTXR), a late-stage biopharmaceutical company developing and commercializing first-in-class critical care products, today announced that it has deployed an

(NASDAQ:IINN), RA'ANANA, Israel, Aug. 22, 2025 (GLOBE NEWSWIRE) — Inspira(TM) Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (“Inspira,” “Inspira Technologies,” or the “Company“), a pioneer in innovative life-support and diagnostic technologies, has received U.S. Patent approval for low flow rates extracorporeal oxygenation system and methods of use. This patent represents the core technology of the ART500

(TSX-V:SCAN),(Boerse Frankfurt – Freiverkehr:LD2A),(OTC US:LDDFF),(Other OTC:LDDFF),(Boerse Frankfurt – Freiverkehr:E30), WILMINGTON, Mass., Aug. 22, 2025 (GLOBE NEWSWIRE) — Liberty Defense Holdings Ltd. (“Liberty” or the “Company“) (TSXV: SCAN, OTCQB: LDDFF, FSE:E30), a leading technology provider of AI-based next generation detection solutions for concealed weapons and threats, announces that it has entered into a marketing agreement dated

Levi &Korsinsky, LLP notifies investors in Charter Communications, Inc. (“Charter Communications, Inc.” or the “Company”) (NASDAQ: CHTR) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Charter Communications, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all persons

Levi & Korsinsky, LLP notifies investors in Unicycive Therapeutics, Inc. (“Unicycive Therapeutics, Inc.” or the “Company”) (NASDAQ: UNCY) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Unicycive Therapeutics, Inc. investors who were adversely affected by alleged securities fraud between March 29, 2024 and June 27,

Levi & Korsinsky, LLP notifies investors in KinderCare Learning Companies, Inc. (“KinderCare Learning Companies, Inc.” or the “Company”) (NYSE: KLC) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of KinderCare Learning Companies, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on

Levi &Korsinsky, LLP notifies investors in Altimmune, Inc. (“Altimmune” or the “Company”) (NASDAQ: ALT) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Altimmune investors who were adversely affected by alleged securities fraud between August 10, 2023 and June 25, 2025. Follow the link below to

Levi & Korsinsky, LLP notifies investors in Tesla, Inc. (“Tesla, Inc.” or the “Company”) (NASDAQ: TSLA) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Tesla, Inc. investors who were adversely affected by alleged securities fraud between April 19, 2023 and June 22, 2025. Follow the